ENFN vs. CME

Last updated Jun 4, 2026

ENFN (Enfusion, Inc.) and CME (CME Group Inc.) are both stocks. ENFN operates in Software - Application (Technology), while CME operates in Financial Data & Stock Exchanges (Financial Services).

Performance

ENFN vs. CME - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Enfusion, Inc. (ENFN) and CME Group Inc. (CME). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

ENFN

• 1D: 0.00%
• 1M: 0.00%
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

CME

• 1D: 0.84%
• 1M: -12.97%
• YTD: -5.27%
• 6M: -5.27%
• 1Y: -7.08%
• 3Y*: 15.77%
• 5Y*: 7.35%
• 10Y*: 14.41%

*Multi-year figures are annualized to reflect compound growth (CAGR)

ENFN vs. CME - Yearly Performance Comparison

	2026 (YTD)
ENFN Enfusion, Inc.	0.00%
CME CME Group Inc.	-14.42%

Fundamentals

Total Revenue (TTM) ENFN : $201.61M CME : $6.76B
Gross Profit (TTM) ENFN : $136.74M CME : $5.84B
EBITDA (TTM) ENFN : $14.66M CME : $5.69B

Return for Risk

ENFN vs. CME — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CME

CME Risk / Return Rank: 23
CME Sharpe Ratio Rank: 25
CME Sortino Ratio Rank: 22
CME Omega Ratio Rank: 22
CME Calmar Ratio Rank: 29
CME Martin Ratio Rank: 14

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ENFN vs. CME - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Enfusion, Inc. (ENFN) and CME Group Inc. (CME). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Sharpe Ratios by Period

	ENFN	CME	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	—	-0.35	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	0.37	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.61	—
Sharpe Ratio (All Time) Calculated using the full available price history	—	0.59	—

Drawdowns

ENFN vs. CME - Drawdown Comparison

The maximum ENFN drawdown since its inception was 0.00%, smaller than the maximum CME drawdown of -77.50%. Use the drawdown chart below to compare losses from any high point for ENFN and CME.

Drawdown Indicators

	ENFN	CME	Difference
Max Drawdown Largest peak-to-trough decline	0.00%	-77.50%	+77.50%
Max Drawdown (1Y) Largest decline over 1 year	—	-21.42%	—
Max Drawdown (3Y) Largest decline over 3 years	—	-21.42%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-31.74%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-37.36%	—
Current Drawdown Current decline from peak	0.00%	-20.76%	+20.76%
Average Drawdown Average peak-to-trough decline	0.00%	-20.69%	+20.69%
Ulcer Index Depth and duration of drawdowns from previous peaks	—	6.03%	—

Volatility

Volatility by Period

	ENFN	CME	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	9.91%	—
Volatility (6M) Calculated over the trailing 6-month period	—	16.74%	—
Volatility (1Y) Calculated over the trailing 1-year period	0.00%	20.47%	-20.47%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	0.00%	20.03%	-20.03%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	0.00%	23.87%	-23.87%

Dividends

ENFN vs. CME - Dividend Comparison

ENFN has not paid dividends to shareholders, while CME's dividend yield for the trailing twelve months is around 4.43%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
CME CME Group Inc.	4.43%	1.83%	4.48%	4.58%	5.05%	3.00%	3.24%	2.74%	2.42%	4.20%	4.90%	5.41%
ENFN Enfusion, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials